These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 11145861

  • 1. Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions.
    Behar SM, Cardell S.
    Semin Immunol; 2000 Dec; 12(6):551-60. PubMed ID: 11145861
    [Abstract] [Full Text] [Related]

  • 2. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J, Berntman E, Stenström M, Smith EM, Månsson R, Stenstad H, Yamagata T, Agace W, Sigvardsson M, Cardell SL.
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [Abstract] [Full Text] [Related]

  • 3. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M, Sköld M, Andersson A, Cardell SL.
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [Abstract] [Full Text] [Related]

  • 4. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G, Berg M, Jüngerkes F, Diehl L, Sullivan BA, Kronenberg M, Limmer A, Knolle PA.
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [Abstract] [Full Text] [Related]

  • 5. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E, Alonso C, Solana R.
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S, Yamamura T.
    Int Rev Immunol; 2007 Aug; 26(1-2):73-94. PubMed ID: 17454265
    [Abstract] [Full Text] [Related]

  • 7. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus.
    Exley MA, Bigley NJ, Cheng O, Tahir SM, Smiley ST, Carter QL, Stills HF, Grusby MJ, Koezuka Y, Taniguchi M, Balk SP.
    J Leukoc Biol; 2001 May; 69(5):713-8. PubMed ID: 11358978
    [Abstract] [Full Text] [Related]

  • 8. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK, Weerasinghe A, Halder RC, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T.
    Cell Immunol; 2001 Aug 01; 211(2):96-104. PubMed ID: 11591113
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium.
    Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL.
    Eur J Immunol; 2005 Jul 01; 35(7):2100-9. PubMed ID: 15940666
    [Abstract] [Full Text] [Related]

  • 13. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
    Florence WC, Bhat RK, Joyce S.
    Expert Rev Mol Med; 2008 Jul 07; 10():e20. PubMed ID: 18601810
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A, Wigren M, Hultgårdh-Nilsson A, Saxena A, Gomez MF, Cardell S, Fredrikson GN, Nilsson J.
    Circ Res; 2007 Oct 12; 101(8):e83-9. PubMed ID: 17885216
    [Abstract] [Full Text] [Related]

  • 16. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB, Beermann F, Lees RK, Schümann J, Zimmer J, Held W, MacDonald HR.
    J Exp Med; 2003 Apr 07; 197(7):919-25. PubMed ID: 12682111
    [Abstract] [Full Text] [Related]

  • 17. NKT cells derive from double-positive thymocytes that are positively selected by CD1d.
    Gapin L, Matsuda JL, Surh CD, Kronenberg M.
    Nat Immunol; 2001 Oct 07; 2(10):971-8. PubMed ID: 11550008
    [Abstract] [Full Text] [Related]

  • 18. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.
    Chiu YH, Park SH, Benlagha K, Forestier C, Jayawardena-Wolf J, Savage PB, Teyton L, Bendelac A.
    Nat Immunol; 2002 Jan 07; 3(1):55-60. PubMed ID: 11731798
    [Abstract] [Full Text] [Related]

  • 19. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
    Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, Deng Y.
    Exp Gerontol; 2007 Aug 07; 42(8):719-32. PubMed ID: 17368996
    [Abstract] [Full Text] [Related]

  • 20. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M, Sköld M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Lehuen A, Cardell S.
    Eur J Immunol; 2004 Jan 07; 34(1):56-65. PubMed ID: 14971030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.